How The U.S. Patent Office Is Keeping Up With AI

Tessa Schwartz spoke to VentureBeat about how existing intellectual property and patent laws can address the unique challenges presented by artificial intelligence.

According to Tessa, there’s a tricky issue at the intersection of transparency and patent law due to the “tension between the desire to maintain confidentiality and ownership of data and algorithms and the necessity of making available data inputs and outputs and AI developments to third parties.”

“If not properly handled, access can result in a […]

By | Jan 24, 2021 ||

Instead Of Clarifying Trademark Law, Brunetti Provides The Roadmap For Future Uncertainty

Three years ago, the United States Supreme Court decided Matal v. Tam, which involved a facial challenge to 15 U.S.C. §1052(a), the disparagement clause of the Lanham Act.1 The lead singer of a musical group consisting of Asian Americans sought a trademark for their group’s name, “The Slants.”2 The term is a derogatory reference to people of Asian descent, and the group’s goal in choosing the name was “reclaim[ing]” and “tak[ing] ownership” of the stereotype.3 The trademark application […]

By | Jan 22, 2021 ||

What’s Next For U.S. Biosimilar Litigation

Kramer Levin Naftalis & Frankel LLP attorneys discuss the direction of biosimilar litigation from recent federal court rulings. They also look at trends in patent litigation and what to expect in 2021 and beyond.

The Biologics Price Competition and Innovation Act (BPCIA) turned 10 this year, making it a good time to look at recent litigation trends and assess what’s ahead for 2021.

U.S. biosimilar litigation continues to take shape, although most cases have resolved without a decision […]

By | Jan 20, 2021 ||